1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Joel Greenberger: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) Manganese Superoxide Dismutase Plasmid Liposome, carboplatin, paclitaxel - Esophageal, Toxicity | Phase 1 / Phase 2 | Terminated | Joel Greenberger | 18 | 2005-11-11 | 2021-11-12 |
Lung Neoplasms (1) · Radiation Injuries (1)
Carboplatin (1) · Paclitaxel (1) · Radiotherapy (1)
United States (1)